S. Marakatham1*, Meruva Sathish Kumar2, A. Kavya1, B. Ramu3, Prathibha Bharathi Mare4
1Malla Reddy institute of Pharmaceutical sciences(MRVU), Maisammaguda, Dhulapally, Kompally Post, Secunderabad-500100, India
2MNR College of Pharmacy, Fasalwadi, Sangareddy-502294, India
3KVK College of Pharmacy, Surmaiguda, Rangareddy, 501512, India
4Gokaraju Rangaraju College of Pharmacy, Hyderabad, India
* Address for Correspondence:
Dr. S. Marakatham
Malla Reddy institute of Pharmaceutical sciences (MRVU),
Maisammaguda, Dhulapally, Kompally Post, Secunderabad-500100, India
Email: Sathishmeruva85@gmail.com
Abstract
The RP-HPLC methodology was used to establish a straightforward, accurate, and precise method for estimating Lanadelumab. The following chromatographic conditions were used: 5. Mobile phase: 0.1% OPA buffer: Acetonitrile in a ratio of 65:35; 5. Stationary phase: Agilent C18 250 x 4.6 mm; 5. Detection wavelength: 228.0 nm; column temperature: 30 °C; diluent: 50:50 acetonitrile: water; retention time: 2.280 min. As the most efficient approach, conditions were finalized. The standard was injected six times to study the system appropriateness characteristics, and the results fell well within the acceptable range. An analysis of linearity was conducted at 25% to 150% levels, and the R2 score was 0.999. Standard precision was determined to be 0.8, whereas repeatable precision was found to be 0.5. 0.08µg/ml is the LOD, while 0.24µg/ml is the LOQ. The assay of the marketed formulation was conducted using the described method, and 100.14% was found.
Keywords HPLC, Lanadelumab
